MONOGRAM BIOSCIENCES, INC.
Patent Owner
Stats
- 86 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Dec 12, 2017 most recent publication
Details
- 86 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 10,712 Total Citation Count
- Nov 08, 1994 Earliest Filing
- 55 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2010/0070,184 METHOD FOR DETERMINING RESISTANCE OF HIV TO PROTEASE INHIBITOR TREATMENTJan 19, 07Mar 18, 10[C12Q, G06F]
2009/0215,028 Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIVFeb 16, 06Aug 27, 09[C07H, C12Q, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9841425 Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysOct 29, 15Dec 12, 17[A61K, C12Q, G01N, C07K]
9506121 Methods for determining resistance or susceptibility to HIV entry inhibitorsJun 06, 06Nov 29, 16[C12Q]
9493847 Molecular determinants in the HIV-1 envelope associated with enhanced ability to enter CXCR4-expressing cellsFeb 09, 12Nov 15, 16[C12Q]
9175355 Methods for determining the presence of antibodies blocking viral infectionDec 10, 09Nov 03, 15[C12Q, G01N, C07K]
8637252 Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugsNov 15, 11Jan 28, 14[A61K, C12Q]
8603736 Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assaysJun 06, 05Dec 10, 13[C12Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0003,667 ELECTROPHORETIC TAG-BASED IN VITRO ASSAY TO QUANTIFY DIMERIZATION OF P66 AND P51 SUB-UNITS OF HIV-1 REVERSE TRANSCRIPTASE (RT)AbandonedJun 16, 08Jan 05, 12[G01N]
2011/0275,096 Detection of Activation of Endothelial Cells as Surrogate Marker for AngiogenesisAbandonedMay 09, 11Nov 10, 11[G01N]
7579143 Method of assessing the effectiveness of a non-nucleoside reverse transcriptase inhibitor (NNRTI) on a human immunodeficiency virus type 1 (HIV-1)-infected patientExpiredJan 14, 04Aug 25, 09[C12Q]
2009/0087,841 METHODS AND COMPOSITIONS FOR DETERMINING RESISTANCE OF HIV-1 TO PROTEASE INHIBITORSAbandonedMay 25, 06Apr 02, 09[C12Q]
2009/0011,440 Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And TherapyAbandonedJul 21, 08Jan 08, 09[C12Q, G01N]
2008/0293,038 Method for Determining Resistance of Hiv to Nucleoside Reverse Transcriptase Inhibitor TreatmentAbandonedMay 25, 06Nov 27, 08[C12Q]
2008/0254,497 Response Predictors for Erbb Pathway-Specific DrugsAbandonedOct 17, 05Oct 16, 08[C12Q]
2008/0044,810 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSAbandonedFeb 08, 07Feb 21, 08[C12Q]
2007/0158,193 Analyte Identification in Transformed ElectropherogramsAbandonedAug 07, 06Jul 12, 07[G01N, B01D]
2007/0099,296 Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugsAbandonedJun 14, 06May 03, 07[C12Q, C12N]
7186506 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSExpiredSep 15, 00Mar 06, 07[C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.